Fructooligosaccharide and Calcium Absorption in Adolescent Girls
This study has been completed.
Sponsor:
Purdue University
Collaborators:
Abbott Nutrition
GTC Nutrition
Information provided by:
Purdue University
ClinicalTrials.gov Identifier:
NCT01005927
First received: October 30, 2009
Last updated: July 27, 2010
Last verified: July 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Fructooligosaccharides (FOS) are believed to have positive effects on calcium absorption and bone accrual during growth. This study aims to see whether the addition of fiber in the form of FOS to a calcium-containing beverage will increase calcium absorption. During two clinical visits, participants will receive a beverage containing a small amount of calcium, supplemented with either no dietary fiber or a small amount of fiber. Height, weight, bone density and geometry, calcium absorption, and physical fitness will be measured. The effects of this fiber intervention may provide support for improving bone health with minimal fiber supplementation.
| Condition | Intervention | Phase |
|---|---|---|
|
Osteoporosis |
Dietary Supplement: Fructooligosaccharide |
Phase 1 Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Single Blind (Subject) Primary Purpose: Prevention |
| Official Title: | Fructooligosaccharide and Calcium Absorption in Adolescent Girls |
Resource links provided by NLM:
Further study details as provided by Purdue University:
Primary Outcome Measures:
- Fractional Calcium Absorption [ Time Frame: 24 h urine and 3 h blood ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Bone density and geometry measured with peripheral quantitative computed tomography (pQCT) [ Time Frame: Initial visit ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 26 |
| Study Start Date: | January 2009 |
| Study Completion Date: | June 2009 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Placebo Comparator: No Fructooligosaccharide
0 g fructooligosaccharide added to calcium-containing beverage
|
Dietary Supplement: Fructooligosaccharide
Zero or 3 g of a fructooligosaccharide will be administered in a beverage containing 300 mg total calcium as well as 15 mg 44Ca (calcium carbonate). Participants will be given one of the above beverages in addition to intravenously receiving 5 mg 43Ca (calcium chloride)in 10 ml saline.
Other Name: Fiber and Calcium
|
|
Active Comparator: 3 g Fructooligosaccharide
3 g fructooligosaccharide added to calcium-containing beverage
|
Dietary Supplement: Fructooligosaccharide
Zero or 3 g of a fructooligosaccharide will be administered in a beverage containing 300 mg total calcium as well as 15 mg 44Ca (calcium carbonate). Participants will be given one of the above beverages in addition to intravenously receiving 5 mg 43Ca (calcium chloride)in 10 ml saline.
Other Name: Fiber and Calcium
|
Eligibility| Ages Eligible for Study: | 10 Years to 12 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Female
- Calcium intake of 900-1300 mg/d
- Generally healthy
Exclusion Criteria:
- Male
- BMI > 90th percentile for age
- Takes medication that influences calcium metabolism
- Any disorder of calcium or bone homeostasis (hypercalcemia, Paget's Disease)
- Smoking, illegal drug consumption
- Any gastrointestinal disease (Crohn's Disease, Celiac Disease, Inflammatory Bowel Disease)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01005927
Locations
| United States, Indiana | |
| Purdue University | |
| West Lafayette, Indiana, United States, 47907 | |
Sponsors and Collaborators
Purdue University
Abbott Nutrition
GTC Nutrition
Investigators
| Principal Investigator: | Connie M Weaver, PhD | Purdue University |
| Study Director: | Berdine R Martin, PhD | Purdue University |
More Information
No publications provided
| Responsible Party: | Connie M Weaver, PhD, Purdue University |
| ClinicalTrials.gov Identifier: | NCT01005927 History of Changes |
| Other Study ID Numbers: | GTC Study |
| Study First Received: | October 30, 2009 |
| Last Updated: | July 27, 2010 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Purdue University:
|
Calcium Bone and Bones Girls Bone Mineralization Fiber |
Fructooligosaccharide Female Healthy Adolescents |
Additional relevant MeSH terms:
|
Osteoporosis Bone Diseases, Metabolic Bone Diseases Musculoskeletal Diseases |
Calcium, Dietary Bone Density Conservation Agents Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 23, 2013